INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Apr 04, 2011 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 92,308 | $13.00 | 142,658 |
| Apr 04, 2011 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 92,308 | -- | -- |
| Dec 15, 2003 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 92,308 | -- | 92,308 |
| Jul 24, 2009 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 89,463 | $9.49 | 89,813 |
| Jul 24, 2009 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 89,463 | -- | -- |
| Dec 15, 2004 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 89,463 | -- | 89,463 |
| Sep 06, 2011 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 82,818 | $11.64 | 133,168 |
| Sep 06, 2011 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 82,818 | -- | -- |
| Dec 19, 2005 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 82,818 | -- | 82,818 |
| Dec 16, 2014 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 80,750 | -- | 80,750 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.